Abstract
To our knowledge, there are no publications regarding ocular complications following hand transplantation. The reasons are that this is a recently developed practice, cases are numerically limited and follow-up is necessarily short. However, one can presume that these complications can be considered comparable with the wider cases available for liver, kidney and heart transplant patients undergoing similar immunosuppressive therapy.
Keywords
- Diabetic Retinopathy
- Proliferative Diabetic Retinopathy
- Central Serous Chorioretinopathy
- Ocular Complication
- Neovascular Glaucoma
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Lanzetta M, Petruzzo P, Vitale G et al (2004) Human hand transplantation: what have we learned? Transplant Proc 36:664–668
Shimmyo A, Miyazaky S, Onoe S et al (1997) Ocular complications after renal transplantation. Nippon Ganka Gakkai Zasshi 101:220–226
Veenstra DL, Best JH, Hornberg J et al (1999) Incidence and cost of steroid side-effects after renal transplantation. Am J Kidney Dis 33:829–839
Black RL, Oglesby RB, von Sallmann L, Bunim JJ (1960) Posterior subcapsular cataracts induced by corticosteroids in patients with rheumatoid arthritis. JAMA 174:150–155
Nishimoto K, Sasaki K, Yamamura T et al (1992) Cataract in renal transplantation recipients with combination cyclosporine treatment. Lens Eye Toxic Res 9:455–467
Jobling AI, Augusteyn RC (2002) What causes steroid cataracts? A review of steroid-induced posterior subcapsular cataracts. Clin Exp Optom 85:2:61–75
Haimovici R, Koh S, Gagnon DR, Lehrfeld T (2004) Risk factors for central serous chorioretinopathy, a case control study. Ophthalmology 111:244–249
Bandello F, Incorvaia C, Rosa N et al (2002) Bilateral central serous chorioretinopathy in a patient treated with systemic corticosteroids for non-Hodgkin’s lymphoma. Eur J Ophthalmol 2:123–126
Levy J, Marcus M, Belfair N et al (2005) Central serous chorioretinopathy in patients receiving systemic corticosteroid therapy. Can J Ophthalmol 40:217–221
Jampol LM, Weired R, Yannuzzi L (2002) Involvement of corticosteroids and catecholamines in the pathogenesis of central serous chorioretinopathy: a rationale for new treatment strategies. Ophthalmology 109:1765–1766
Jampol LM, Yanuzzi LA, Weinreb RN (2005) Glaucoma and intravitreal steroids. Ophthalmology 112:1325–1326
Shutter LA, Green JP, Newmann NJ et al (1993) Cortical blindness and white matter lesion in a patient receiving FK506 after liver transplantation. Neurology 43:2417–2418
Devine SM, Newmann NJ, Siegal JL et al (1996) Tacrolimus (FK506) induced cerebral blindness following bone marrow transplantation. Bone Marrow Transplant 18:569–572
Steg RE, Kessinger A, Wszolek ZK (1999) Cortical blindness and seizures in a patient receiving FK506 after bone marrow transplantation. Bone Marrow Transplant 23:959–952
Brazis PW, Spivey JR, Bolling JP, Steers JL (2000) A case of bilateral optic neuropathy in a patient on tacrolimus (FK506) therapy after liver transplantation. Am J Ophthalmol 536–538
Lanzetta P, Monaco P (2004) Major ocular complications after organ transplantation. Transplant Proc 3046–3048
Ishida H, Mitamura T, Takahashy Y et al (1997) Cataract development induced by repeated oral dosing with FK506 (tacrolimus) in adult rats. Toxicology 123:167–175
Zoja C, Furci L, Ghilardi F et al (1986) Cyclosporin-induced endothelial cell injury. Lab Invest 55:455–462
O’Riordan JM, FitzSimon S, O’Connor M, McCann SR (1994) Retinal microvascular changes following bone marrow transplantation: the role of cyclosporine. Bone Marrow Transplant 13:101–104
Moon SJ, Mieler WF (2003) Retinal complications of bone marrow and solid organ transplantation. Curr Opin Ophthalmol 14:433–442
Openshaw H, Slatkin NE, Smith E (1997) Eye movement disorders in bone marrow transplant patients on cyclosporine and ganciclovir. Bone Marrow Transplant 19:503–505
Nakamura T, Sasaki H, Nagai K et al (2003) Influence of cyclosporin on steroid-induced cataracts after renal transplantation. Jpn J Ophthalmol 47:254–259
Guembel HO, Ohroff C (1997) Opportunistic infections of the eye in immunocompromised patients. Ophthalmologica 2:123–126
Ng P, McCluskey P, McCaughan G et al (1998) Ocular complications of heart, lung and liver transplantation. Br J Ophthalmol 82:423–42
Lalezari JP, Friedberg DN, Bisset J et al (2002) High dose oral ganciclovir treatment for cytomegalovirus retinitis. J Clin Virol 24(1–2):67–77
Martin DF, Sierra-Madero J, Walmsley S et al (2002) A controlled trial of valganciclovir induction therapy for cytomegalovirus retinitis. N Engl J Med 346:1119
Mehta S (2004) Major ocular complications after organ transplantation. Indian J Ophthalmol 52:255–256
Obayashi PA (2004) Posttransplant diabetes mellitus: cause, impact, and treatment options. Nutr Clin Pract 19:165–171
Roozbeh J, Mehdizadeh AR, Razmkon A, Malek-Hosseini SA (2005) Incidence of posttransplantation diabetes mellitus in kidney transplantation: a single-center experience. Transplant Proc 37:3095–3097
Jindal RM, Sidner RA, Milgrom ML (1997) Post-transplant diabetes mellitus. The role of immunosuppression. Drug Saf 16:242–257
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Springer-Verlag Italia
About this chapter
Cite this chapter
Veritti, D., Marco, L. (2007). Ocular Complications after Hand Transplantation. In: Lanzetta, M., Dubernard, JM., Petruzzo, P. (eds) Hand Transplantation. Springer, Milano. https://doi.org/10.1007/978-88-470-0374-3_31
Download citation
DOI: https://doi.org/10.1007/978-88-470-0374-3_31
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-0373-6
Online ISBN: 978-88-470-0374-3
eBook Packages: MedicineMedicine (R0)